Literature DB >> 20801594

Validity of T2 mapping in characterization of the regeneration tissue by bone marrow derived cell transplantation in osteochondral lesions of the ankle.

M Battaglia1, E Rimondi, C Monti, F Guaraldi, A Sant'Andrea, R Buda, M Cavallo, S Giannini, F Vannini.   

Abstract

OBJECTIVE: Bone marrow derived cell transplantation (BMDCT) has been recently suggested as a possible surgical technique to repair osteochondral lesions. To date, no qualitative MRI studies have evaluated its efficacy. The aim of our study is to investigate the validity of MRI T2-mapping sequence in characterizing the reparative tissue obtained and its ability to correlate with clinical results. METHODS AND MATERIALS: 20 patients with an osteochondral lesion of the talus underwent BMDCT and were evaluated at 2 years follow up using MRI T2-mapping sequence. 20 healthy volunteers were recruited as controls. MRI images were acquired using a protocol suggested by the International Cartilage Repair Society, MOCART scoring system and T2 mapping. Results were then correlated with AOFAS clinical score.
RESULTS: AOFAS score increased from 66.8±14.5 pre-operatively to 91.2±8.3 (p<0.0005) at 2 years follow-up. T2-relaxation time value of 35-45 ms was derived from healthy ankles evaluation and assumed as normal hyaline cartilage value and used as a control. Regenerated tissue with a T2-relaxation time value comparable to hyaline cartilage was found in all the cases treated, covering a mean of 78% of the repaired lesion area. A high clinical score was related directly to isointense signal in DPFSE fat sat (p=0.05), and percentage of regenerated hyaline cartilage (p=0.05), inversely to the percentage of regenerated fibrocartilage. Lesion's depth negatively related to the integrity of the repaired tissue's surface (tau=-0.523, p=0.007), and to the percentage of regenerated hyaline cartilage (rho=-0.546, p=0.013).
CONCLUSIONS: Because of its ability to detect cartilage's quality and to correlate to the clinical score, MRI T2-mapping sequence integrated with Mocart score represent a valid, non-invasive technique for qualitative cartilage assessment after regenerative surgical procedures.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20801594     DOI: 10.1016/j.ejrad.2010.08.008

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  21 in total

1.  Regenerative treatment in osteochondral lesions of the talus: autologous chondrocyte implantation versus one-step bone marrow derived cells transplantation.

Authors:  Roberto Buda; Francesca Vannini; Francesco Castagnini; Marco Cavallo; Alberto Ruffilli; Laura Ramponi; Gherardo Pagliazzi; Sandro Giannini
Journal:  Int Orthop       Date:  2015-02-08       Impact factor: 3.075

2.  Chevron-type medial malleolar osteotomy: a functional, radiographic and quantitative T2-mapping MRI analysis.

Authors:  Joshua Lamb; Christopher D Murawski; Timothy W Deyer; John G Kennedy
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-05-16       Impact factor: 4.342

3.  T2-mapping at 3 T after microfracture in the treatment of osteochondral defects of the talus at an average follow-up of 8 years.

Authors:  Christoph Becher; David Zühlke; Christian Plaas; Marc Ewig; Tilman Calliess; Christina Stukenborg-Colsman; Hajo Thermann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-23       Impact factor: 4.342

4.  Large variation in management of talar osteochondral lesions among foot and ankle surgeons: results from an international survey.

Authors:  Matteo Guelfi; Christopher W DiGiovanni; James Calder; Francesc Malagelada; Guillaume Cordier; Masato Takao; Jorge Batista; Caio Nery; Marino Delmi; Miki Dalmau-Pastor; Giovanni Carcuro; Gabriel Khazen; Jordi Vega
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-11-22       Impact factor: 4.342

Review 5.  Operative Treatment for Osteochondral Lesions of the Talus: Biologics and Scaffold-Based Therapy.

Authors:  Youichi Yasui; Adi Wollstein; Christopher D Murawski; John G Kennedy
Journal:  Cartilage       Date:  2016-05-09       Impact factor: 4.634

6.  Return to Sports After Bone Marrow-Derived Cell Transplantation for Osteochondral Lesions of the Talus.

Authors:  Francesca Vannini; Marco Cavallo; Laura Ramponi; Francesco Castagnini; Simone Massimi; Sandro Giannini; Roberto Emanuele Buda
Journal:  Cartilage       Date:  2016-04-12       Impact factor: 4.634

7.  Arthroscopic autologous chondrocyte implantation in osteochondral lesions of the talus: mid-term T2-mapping MRI evaluation.

Authors:  Milva Battaglia; Francesca Vannini; Roberto Buda; Marco Cavallo; Alberto Ruffilli; Carlo Monti; Stefano Galletti; Sandro Giannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-04-19       Impact factor: 4.342

Review 8.  Mesenchymal Stromal Cells in Osteoarthritis: Evidence for Structural Benefit and Cartilage Repair.

Authors:  Yujie Song; Christian Jorgensen
Journal:  Biomedicines       Date:  2022-05-30

9.  Clinical outcome and T2 assessment following autologous matrix-induced chondrogenesis in osteochondral lesions of the talus.

Authors:  Eva Johanna Kubosch; Benjamin Erdle; Kaywan Izadpanah; David Kubosch; Markus Uhl; Norbert P Südkamp; Philipp Niemeyer
Journal:  Int Orthop       Date:  2015-09-08       Impact factor: 3.075

10.  Platelet-rich plasma to treat ankle cartilage pathology - from translational potential to clinical evidence: a systematic review.

Authors:  Francesca Vannini; Berardo Di Matteo; Giuseppe Filardo
Journal:  J Exp Orthop       Date:  2015-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.